News
China: A new study, published in Diabetes, Metabolic Syndrome and Obesity, has shed light on the potential role of specific ...
AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss: Study
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels ...
USA: Individuals with rheumatoid arthritis (RA) who also suffer from associated lung conditions face a significantly higher ...
USA: Researchers have found in a new study that patients with idiopathic intracranial hypertension (IIH) treated with ...
A new study published in the Journal of Digestive Diseases found a significant increase in gallstone disease in the U.S., ...
A new study published in the journal of Risk Management and Healthcare Policy showed that the frequency of magnesium ...
Our metabolic processes differ depending on the time of day and many of them are more active in the morning than in the ...
A landmark 30-year study of over four million women in England has revealed that women with endometriosis-associated infertility are significantly more likely to become pregnant compared to ...
Pediatric PAH, a rare yet life-threatening condition, results from obstructive changes in the pulmonary vasculature that ...
In a year-long phase II trial, Ambroxol, a widely used cough medicine in Europe, showed target engagement in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results